The results
of this study provide a new window toward the development
of a new
class of drugs with a novel target unexplored until now,» said corresponding author Pietro Cottone, PhD, co-director
of the Laboratory
of Addictive Disorders (LAD) and associate professor
of pharmacology and psychiatry at BUSM.